We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Infringement Claims Nixed In Focalin Patent Suits

Law360 (January 13, 2009, 12:00 AM EST) -- Continuing a trend in Focalin patent litigation, a federal judge has tossed claims for willful infringement from two actions filed by Celgene Corp. and Novartis Pharmaceuticals Corp. to block generic versions...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.